drugset / Trial / NCT00762359
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether lansoprazole, once daily (QD), compared to gefarnate, twice daily (BID), is effective in preventing the recurrence of gastric and duodenal ulcers in patients receiving long term treatment with low dosage aspirin.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gefarnate | Small molecule | 50 mg | Oral |
| Subject | Lansoprazole | Other / unclassified | 15 mg | Oral |